RxDoctor Payments Data

Zachary Coon, DO

Family Medicine · Tucson, AZNPI 1528696218

Payments from drug & device makers

$175in general payments, 2019–2025

Across 10 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$38
  • Lilly USA, LLC$38
  • Boehringer Ingelheim$25
  • AbbVie$23
  • GSK$22
  • Pfizer$15
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$175100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk2$38
Lilly USA, LLC2$38
Boehringer Ingelheim2$25
AbbVie1$23
GSK1$22
Pfizer1$15
AstraZeneca1$14

How this compares

$175 in reported general payments places this provider in the 40th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$61,125
Medicare patients
228
Services billed
769

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin34$43,364
MounjaroTirzepatide30$35,502
OzempicSemaglutide14$20,648
EliquisApixaban21$20,574
TrulicityDulaglutide14$14,287
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,445
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$4,978
Albuterol Sulfate HfaAlbuterol Sulfate64$1,436
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$1,424
Lidocaine13$1,060
Valsartan46$1,017
Rosuvastatin Calcium120$1,008
Levothyroxine Sodium105$895
Atorvastatin Calcium102$836
Tamsulosin Hcl32$798

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$38$49,78944 claims
Boehringer IngelheimJardiance$25$43,36434 claims
Novo NordiskOzempic$38$20,64814 claims
PfizerEliquis$15$20,57421 claims
GSKTrelegy Ellipta, Anoro Ellipta$22$16,42431 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →